Single-agent Cobimetinib for Adults With Histiocytic Disorders

Clinical trial NCT02649972 · COMPLETED

Trial details

NCT number: NCT02649972
Sponsor: Memorial Sloan Kettering Cancer Center
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Histiocytic Disorders

Start date: 2016-01-01
Primary completion: 2022-12-16
Enrollment: 35

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.